1. Heidari Soureshjani E., Doosti A.. Examination methicillin-resistant Staphylococcus aureus (MRSA) prevalence in cockroaches from hospital in Chaharmahal-va-Bakhtiari province, Iran by polymerase chain reaction (PCR). Acad J 5(7):2013 July;324-329.
2. Nejati J., Keyhani A., Moosa-Kazemi S.H.. Cockroaches' bacterial infections in wards of hospitals, Hamedan city, west of Iran. Asian Pac J Trop Dis 2(5):2012 Oct;381-384.
3. Birkneh T., Bogale W., Erdaw T.. High load of multi-drug resistant nosocomial neonatal pathogens carried by cockroaches in a neonatal intensive care unit at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Antimicrob Resist Infect Control 1(12):2012 Mar;1-7.
4. Fortedor R., Shriniwas U.B., Verma A.. Cockroaches (
Blattella germanica) as carriers of microorganisms of medical importance in hospitals. Epidemiol Infect 107(1):1991 Aug;181-187.
5. Bala A.Y., Sule H.. Vectorial potential of cockroaches in transmitting parasites of medical importance in Arkilla, Sokoto, Nigeria. Nig J Basic Appl Sci 20(2):2012 Jun;111-115.
6. Tachbele E., Erku W., Gebre-Michael T.. Cockroach-associated food-borne bacterial pathogens from some hospitals and restaurants in Addis Ababa, Ethiopia: distribution and antibiograms. J Rural Trop Public Health 5:2006;34-41.
7. Salehzadeh A., Tavacol P., Mahjub H.. Bacterial, fungal and parasitic contamination of cockroaches in public hospitals of Hamadan. Iran J Vector Borne Dis 44(2):2007 Jun;105-110.
8. Cotton M.F., Wasserman E., Pieper C.H.. Invasive disease due to extended spectrum beta-lactamase producing
Klebsiella pneumoniae in a neonatal unit: the possible role of cockroaches. J Hosp Infect 44(1):2000 Jan;13-17.
9. Lawlor M.S., Hsu J., Rick P.D.. Identification of
Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol 58(4):2005 Nov;1054-1073.
10. Mun Teng W., Chee Sian K., Siang Ling C.. Structural modeling and biochemical characterization of recombinant KPN_02809, a zinc-dependent metalloprotease from
Klebsiella pneumoniae MGH 78578. Int J Mol Sci 13:2012 Nov;901-917.
11. Mungloo-Rujubali S.K., Issack M.I., Jaufeerally-Fakim Y.. Study of Klebsiella pneumoniae isolates with ESBL activity, from ICU and nurseries, on the island of Mauritius. J Cell Mol Biol 10(1):2013 Aug;39-51.
12. Wilksch J.J., Yang Ji, Clements A.. MrkH, a novel c-di GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression. PLOS Pathog 7(8):2012 Aug;1-22.
13. Zhao F., Bai J., Zhou M.. Sequencing and genetic variation of multidrug resistance plasmids in Klebsiella pneumoniae. PLoS ONE 5(4):2010 Apr;1-9.
14. Mulvey M.R., Boyd D.A.. TEM-168, a heretofore laboratory-derived TEM β-lactamase variant found in an
Escherichia coli clinical isolate. Antimicrob Agents Chemother 53(11):2009 Nov;4955-4956.
15. Black M.T., Stachyra T., Coleman K.. Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-β-lactam β-lactamase inhibitor. Antimicrob Agents Chemother 54(12):2010 Dec;5132-5180.
16. Sturenburg E., Mack D.. Extended spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 47(4):2003 Nov;273-295.
17. Livermore D.M.. β-lactamase in laboratory and clinical resistance. Clin Microbiol Rev 8(4):1995 Oct;557-584.
18. Jain A., Mondal R.. TEM & SHV genes in extended spectrum β-lactamase producing Klebsiella species & their antimicrobial resistance pattern. Indian J Med Res 128(6):2008 Dec;759-764.
19. Sambrook J., Russell D.W.. Molecular cloning: a laboratory manual. 3rd ed. 2001. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, New York; pp 517,
20. Achouit A., Vogl T., Florquin S.. Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis. PLOS Pathog 8(10):2012;1-14.
21. Medeiros A.A.. Beta-lactamases. Br Med Bull 40(1):1984 Jan;18-27.
22. Shojapour M., Shariati L., Karimi A.. Prevalence of TEM-1 type beta-lactmase genes in Pseudomonas aeruginosa strains isolated from burn infections using duplex PCR in Shahrekord 2008. Arak Med Univ J 14(54):2011;55-61.
23. Jajić-Bencic I., Bedenić B., Mikoc A.. Characterization of extended-spectrum beta-lactamases in Enterobacteriaceae causing nosocomial infections in a Zagreb University Hospital. J Chemother 21(3):2009 Jun;282-289.
24. E. coli
25. Bradford P.A.. Extended spectrum beta-lactamases in 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14(4):2001;933-951.
26. Barroso H., Viera H.A., Lito L.M.. Survey of
K. pneumonia producing extended spectrum beta-lactamase at a Portuguese hospital: TEM-10 as the endemic enzyme. J Antimicrob Chemother 45(5):2000 May;611-616.
27. Kim J., Kwon H., Pai J.. Survey of K. pneumoniae strains producing extended spectrum betalactamase: prevalence of SHV-12 and SHV-2 in Korea. J Clin Microbiol 36:1998;1446-1449.
28. Jain A., Mondal R.. Prevalence and antimicrobial resistant pattern of extended spectrum β-lactamase producing Klebsiella spp. isolated from cases of neonatal septisaemia. Indian J Med Res 125(1):2007 Jan;89-94.
29. Jain A., Roy I., Gupta M.K.. Prevalence of extended spectrum beta-lactamase producing Gram negative bacteria in septicemic neonates in a tertiary care hospital. J Med Microbiol 52(Pt5):2003 May;421-425.
30. Mathur P., Kapil A., Das B.. Prevalence of extended spectrum beta-lactamase producing Gram-negative bacteria in a tertiary care hospital. Indian J Med Res 115:2005 Apr;153-157.
31. Hansotia J.B., Agarwal V., Pathak A.A.. Extended spectrum beta-lactamase mediate resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 105:1997 Apr;158-161.